Medacta Group Statistics
Total Valuation
Medacta Group has a market cap or net worth of CHF 2.47 billion. The enterprise value is 2.65 billion.
Market Cap | 2.47B |
Enterprise Value | 2.65B |
Important Dates
The next estimated earnings date is Wednesday, September 25, 2024.
Earnings Date | Sep 25, 2024 |
Ex-Dividend Date | May 10, 2024 |
Share Statistics
Medacta Group has 19.93 million shares outstanding.
Shares Outstanding | 19.93M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 69.88% |
Owned by Institutions (%) | 16.84% |
Float | 6.00M |
Valuation Ratios
The trailing PE ratio is 56.30 and the forward PE ratio is 37.68.
PE Ratio | 56.30 |
Forward PE | 37.68 |
PS Ratio | 5.21 |
PB Ratio | 8.06 |
P/FCF Ratio | 486.04 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.49, with an EV/FCF ratio of 519.48.
EV / Earnings | 60.01 |
EV / Sales | 5.56 |
EV / EBITDA | 22.49 |
EV / EBIT | 37.15 |
EV / FCF | 519.48 |
Financial Position
The company has a current ratio of 2.33, with a Debt / Equity ratio of 61.74.
Current Ratio | 2.33 |
Quick Ratio | 0.82 |
Debt / Equity | 61.74 |
Debt / EBITDA | 1.61 |
Debt / FCF | 37.24 |
Interest Coverage | 11.20 |
Financial Efficiency
Return on equity (ROE) is 15.66% and return on invested capital (ROIC) is 9.75%.
Return on Equity (ROE) | 15.66% |
Return on Assets (ROA) | 7.47% |
Return on Capital (ROIC) | 9.75% |
Revenue Per Employee | 280,314 |
Profits Per Employee | 25,992 |
Employee Count | 1,696 |
Asset Turnover | 0.80 |
Inventory Turnover | 0.87 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.74% in the last 52 weeks. The beta is 1.14, so Medacta Group's price volatility has been higher than the market average.
Beta (5Y) | 1.14 |
52-Week Price Change | +2.74% |
50-Day Moving Average | 125.08 |
200-Day Moving Average | 123.02 |
Relative Strength Index (RSI) | 42.61 |
Average Volume (20 Days) | 5,166 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medacta Group had revenue of CHF 475.41 million and earned 44.08 million in profits. Earnings per share was 2.21.
Revenue | 475.41M |
Gross Profit | 323.76M |
Operating Income | 71.21M |
Pretax Income | 54.66M |
Net Income | 44.08M |
EBITDA | 111.36M |
EBIT | 71.21M |
Earnings Per Share (EPS) | 2.21 |
Balance Sheet
The company has 19.35 million in cash and 189.65 million in debt, giving a net cash position of -170.30 million or -8.55 per share.
Cash & Cash Equivalents | 19.35M |
Total Debt | 189.65M |
Net Cash | -170.30M |
Net Cash Per Share | -8.55 |
Equity (Book Value) | 307.19M |
Book Value Per Share | 15.42 |
Working Capital | 185.26M |
Cash Flow
In the last 12 months, operating cash flow was 69.93 million and capital expenditures -64.83 million, giving a free cash flow of 5.09 million.
Operating Cash Flow | 69.93M |
Capital Expenditures | -64.83M |
Free Cash Flow | 5.09M |
FCF Per Share | 0.26 |
Margins
Gross margin is 68.10%, with operating and profit margins of 14.98% and 9.27%.
Gross Margin | 68.10% |
Operating Margin | 14.98% |
Pretax Margin | 11.50% |
Profit Margin | 9.27% |
EBITDA Margin | 23.42% |
EBIT Margin | 14.98% |
FCF Margin | 1.07% |
Dividends & Yields
This stock pays an annual dividend of 0.55, which amounts to a dividend yield of 0.43%.
Dividend Per Share | 0.55 |
Dividend Yield | 0.43% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 23.34% |
Buyback Yield | n/a |
Shareholder Yield | 0.43% |
Earnings Yield | 1.78% |
FCF Yield | 0.21% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |